Instrument Inactif

Communiqués Tetraphase Pharmaceuticals, Inc.

Actions

US88165N2045

Produits pharmaceutiques

Communiqués

25/06/20	La Jolla Pharmaceutical Company : to Acquire Tetraphase Pharmaceuticals, Inc	AQ
24/06/20	TETRAPHASE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
24/06/20	Tetraphase Pharmaceuticals : La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.	BU
22/06/20	TETRAPHASE PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22/06/20	Tetraphase Pharmaceuticals : Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta	BU
05/06/20	TETRAPHASE PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
04/06/20	TETRAPHASE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
04/06/20	Tetraphase Pharmaceuticals : Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals	BU
04/06/20	Tetraphase Pharmaceuticals : AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase	PR
01/06/20	TETRAPHASE PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/06/20	Tetraphase Pharmaceuticals : Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx	BU
01/06/20	Tetraphase Pharmaceuticals : ANNOUNCES SECOND AMENDMENT TO MERGER AGREEMENT WITH ACELRX PHARMACEUTICALS FOR INCREASED CONSIDERATION	AQ
29/05/20	TETRAPHASE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
29/05/20	Tetraphase Pharmaceuticals : Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration	BU
29/05/20	Tetraphase Pharmaceuticals : AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase	PR
28/05/20	TETRAPHASE PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
28/05/20	Tetraphase Pharmaceuticals : Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx	BU
27/05/20	Tetraphase Pharmaceuticals : AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase	PR
27/05/20	TETRAPHASE PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
27/05/20	Tetraphase Pharmaceuticals : Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration	BU
22/05/20	TETRAPHASE PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22/05/20	Tetraphase Pharmaceuticals : Announces Determination of Superior Offer and Notice to AcelRx	BU
21/05/20	TETRAPHASE PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
15/05/20	TETRAPHASE PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
13/05/20	TETRAPHASE PHARMACEUTICALS INC : Other Events (form 8-K)	AQ